SS Innovations International (SSII) Enterprise Value (2016 - 2026)
SS Innovations International (SSII) reported Enterprise Value of -$23.6 million for Q1 2026, down 8.51% on a YoY basis from -$25.8 million in Q1 2025, and down 158.21% sequentially from -$9.1 million in Q4 2025.
SS Innovations International (SSII) Enterprise Value (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Enterprise Value data on file, last reported at -$23.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 8.51% year-over-year to -$23.6 million; the trailing twelve-month figure through Mar 2026 stood at -$23.6 million (down 8.51% YoY), and the FY2025 full-year result was -$9.1 million, down 45.03% from the prior year.
- Enterprise Value retreated to -$23.6 million in Q1 2026, from -$9.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$261089.0 in Q2 2022 to a low of -$23.6 million in Q1 2026.
- A 5-year average of -$7.3 million and a median of -$6.3 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 2467.84% in 2023 and soared 50.2% in 2024, its largest moves.
- Tracing SSII's Enterprise Value over 5 years: stood at -$274625.0 in 2022, then sank by 2467.84% to -$7.1 million in 2023, then climbed by 10.59% to -$6.3 million in 2024, then tumbled by 45.03% to -$9.1 million in 2025, then sank by 158.21% to -$23.6 million in 2026.
- Business Quant data shows SSII's Enterprise Value at -$23.6 million in Q1 2026, -$9.1 million in Q4 2025, and -$11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | -23.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.61 Mn |
| Dec 31, 2025 | -9.14 Mn |
| Sep 30, 2025 | -11.71 Mn |
| Jun 30, 2025 | -17.26 Mn |
| Mar 31, 2025 | -21.76 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Jun 30, 2024 | -813,453.00 |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | -7.05 Mn |
| Sep 30, 2023 | -11.61 Mn |
| Jun 30, 2023 | -466,346.00 |
| Mar 31, 2023 | -448,543.00 |
| Dec 31, 2022 | -274,625.00 |
| Sep 30, 2022 | -514,143.00 |
| Jun 30, 2022 | -261,089.00 |
| Mar 31, 2022 | -346,869.00 |
| Dec 31, 2021 | -405,774.00 |
| Sep 30, 2021 | -205,195.00 |
| Jun 30, 2021 | -307,565.00 |